Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|August 25, 2011
Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancerJoanna Zawacka-Pankau, Vera V Grinkevich, Sabine Hünten, et al.
Cell Cycle (Georgetown, Tex.)|September 24, 2011
Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2Hai Li, Tadepally Lakshmikanth, Cinzia Garofalo, et al.
Carcinogenesis|August 3, 2014
Modulation of the poly (ADP-ribose) polymerase inhibitor response and DNA recombination in breast cancer cells by drugs affecting endogenous wild-type p53Ivanildce Cristiane Ireno, Rahel Stephanie Wiehe, Andreea Iulia Stahl, et al.
Cancer Cell|May 5, 2009
Ablation of key oncogenic pathways by RITA-reactivated p53 is required for efficient apoptosisVera V Grinkevich, Fedor Nikulenkov, Yao Shi, et al.
Nature Medicine|March 5, 2002
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compoundVladimir J N Bykov, Natalia Issaeva, Alexandre Shilov, et al.
Cell Death & Disease|November 9, 2019
RITA requires eIF2α-dependent modulation of mRNA translation for its anti-cancer activityJohannes Ristau, Vincent van Hoef, Sylvain Peuget, et al.
Breast Cancer Research : BCR|July 31, 2020
Identification and targeting of selective vulnerability rendered by tamoxifen resistanceMadhurendra Singh, Xiaolei Zhou, Xinsong Chen, et al.
Cell Cycle (Georgetown, Tex.)|December 12, 2018
MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblastsFan Zhang, Siti Mariam Zakaria, Vedrana Högqvist Tabor, et al.
Pageof 6